Riaño, I.; MartÃn, L.; Varela, M.; Serrano, T.; Núñez, O.; MÃnguez, B.; Rodrigues, P.M.; Perugorria, M.J.; Banales, J.M.; Arenas, J.I.
Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial). Cancers 2020, 12, 1900.
https://doi.org/10.3390/cancers12071900
AMA Style
Riaño I, MartÃn L, Varela M, Serrano T, Núñez O, MÃnguez B, Rodrigues PM, Perugorria MJ, Banales JM, Arenas JI.
Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial). Cancers. 2020; 12(7):1900.
https://doi.org/10.3390/cancers12071900
Chicago/Turabian Style
Riaño, Ioana, Leticia MartÃn, Maria Varela, Trinidad Serrano, Oscar Núñez, Beatriz MÃnguez, Pedro M. Rodrigues, Maria J. Perugorria, Jesus M. Banales, and Juan I. Arenas.
2020. "Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)" Cancers 12, no. 7: 1900.
https://doi.org/10.3390/cancers12071900
APA Style
Riaño, I., MartÃn, L., Varela, M., Serrano, T., Núñez, O., MÃnguez, B., Rodrigues, P. M., Perugorria, M. J., Banales, J. M., & Arenas, J. I.
(2020). Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial). Cancers, 12(7), 1900.
https://doi.org/10.3390/cancers12071900